ACRC Building

HYPOACTIVE SEXUAL DESIRE DISORDER IN POSTMENOPAUSAL WOMEN

Summary: This is a 5-year clinical research study to assess the long-term safety and effectiveness of an investigational (not approved by the FDA) drug for women who have gone through menopause or had their ovaries removed and have since experienced a decline in sexual desire, a condition called Hypoactive Sexual Desire Disorder (HSDD).

Participation qualifications:

Benefits:

Study participants may receive study-related medical examinations, laboratory testing, and study medication or a placebo (an inactive substance).

Compensation up to $450.00 for time and travel is also available.

If you are interested in this study, please contact:
 
ACRC/Arizona Clinical Research Center, Inc.
1825 N. Kolb Rd.
Tucson, AZ 85715
Phone: (520) 290-9896
Fax: (520) 290-2508

Participants cannot be enrolled in the clinical study until they have signed an informed consent form, completed screening, and have been fully evaluated at the study site.


Return Home